Boston, MA -- (SBWIRE) -- 10/15/2013 -- Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner.Chartpoppers.com issues news alert on the following stocks:- Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Charles Schwab Corp (NYSE:SCHW), ARMOUR Residential REIT, Inc. (NYSE:ARR), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX).
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) opened its shares at the price of $0.86 for the day. Its closing price was $0.870 for the day. The company traded with the total volume of 703,564 shares, while its average trading volume remained 703,647 shares. The beta of PVCT stands at0.81.
Will PVCT Continue To Move Higher? Find Out Here
Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
Charles Schwab Corp (NYSE:SCHW) percentage change surged1.06 % to close at $22.01 with the total traded volume of 10.33 million shares, and average volume of 9.06 million. The 52 week range of the stock remained $12.47 - $22.84, while its day lowest price was $21.39and it hit its day highest price at $22.08.
Will SCHW Continue To Move Higher? Find Out Here
The Charles Schwab Corporation (CSC) is a savings and loan holding company. The Company engages, through its subsidiaries, in securities brokerage, banking, and related financial services.
ARMOUR Residential REIT, Inc. (NYSE:ARR) started its trading session with the price of $4.19 and closed at $4.17 by scoring -2.48%. ARR’s stocks traded with total volume of 2.59 million shares, while the average trading volume remained 5.21 million shares. The beta of ARR stands at 0.69. Day range of the stock was $4.15 -$4.21.
Will ARR Get Buyers Even After The Recent Rally? Find Out Here
RMOUR Residential REIT, Inc.( ARMOUR) is an externally-managed Maryland corporation managed by ARMOUR Residential REIT, Inc. The Company invests primarily in hybrid adjustable rate, adjustable rate and fixed rate residential mortgage backed securities (RMBS).
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) ended its day with the gain of 0.38% and closed at the price of $2.65 after opening at $2.64. Stock traded during its last trading session with the total volume of 1.12 million shares, as compared to its average volume of 2.56 million shares.
Will CPRX Continue To Move Higher? Find Out Here
Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)